Your science news and technology news centre

Earth Will Likely Dodge 'Planet Killer' Asteroids For The Next 1,000 Years

The good news? No giant asteroids will strike this millennium.

Silicon Valley Is Reviving The Dream Of General-Purpose Humanoid Robots

Most recent was Sanctuary's announcement of its new Phoenix robot last week.

Microsoft Signs Contract To Buy Power From Nuclear Fusion Reactor By 2028

According to the Fusion Industry Association, 33 companies have raised roughly five billion dollars in recent years, and many are predicting that commercial fusion will be a reality by the end of the decade.

Cancer Breakthrough As Scientists Find Way To Block Deadly Disease

Researchers suggest that developing drugs to starve cancer cells of the vital fuel source - uridine - could improve treatment and boost survival rates.

First Immunotherapy Approved For Cervical Cancer In England And Scotland

The immunotherapy drug pembrolizumab (Keytruda) is now available for people in England and Scotland with some forms of advanced cervical cancer.

EU And US Partner On Cancer Research With New Taskforce

The EU and US have launched a taskforce to bolster their collaboration on health topics including cancer research.

Early Cancer Diagnosis And COVID-19: Unpicking The Impact Of The Pandemic

How has the pandemic affected early diagnosis?

Cell ‘nanobot’ Breakthrough Shines Light On Cause Of Aggressive Cancers

Scientists have uncovered the inner workings of one of the most important and intricate ‘nanobots’ operating within our cells, using cutting-edge microscopy for visualising molecules almost at an atomic level.

How MRI Add-ons Could Accelerate The Development Of New Cancer Treatments

If we can implement new techniques like this, that add quick, simple and non-invasive steps to already routinely used tests in the clinic, we can accelerate the development of stromal targeted therapies and improve the effectiveness of chemotherapies in these dense tumours.

How TRACERx Is Helping Us Predict Lung Cancer’s Next Move

The TRACERx team took multiple samples from over 400 tumours to try and determine the order that these subclones developed in, and why certain subclones were selected for where others weren’t. Doing that could give us clues as to what a person’s cancer might do next.

Olaparib Approved For 800 Prostate And Breast Cancer Patients In England

When used after surgery and chemotherapy, the drug can also reduce the risk of BRCA-mutant, HER2-negative early breast cancer returning or getting bigger.

Targeting Uncontrolled Inflammation May Be Key To Treating Resistant Cancers

Van Andel Institute scientists have pinpointed how a specific gene mutation triggers an inflammatory cascade that may drive development of treatment-resistant cancers.